Converging evidence indicates that microRNAs (miRNAs) may contribute to disease risk for schizophrenia (SZ). We show that microRNA-9 (miR-9) is abundantly expressed in control neural progenitor cells (NPCs) but also significantly downregulated in a subset of SZ NPCs. We observed a strong correlation between miR-9 expression and miR-9 regulatory activity in NPCs as well as between miR-9 levels/activity, neural migration, and diagnosis. Overexpression of miR-9 was sufficient to ameliorate a previously reported neural migration deficit in SZ NPCs, whereas knockdown partially phenocopied aberrant migration in control NPCs. Unexpectedly, proteomic- and RNA sequencing (RNA-seq)-based analysis revealed that these effects were mediated primarily by small changes in expression of indirect miR-9 targets rather than large changes in direct miR-9 targets; these indirect targets are enriched for migration-associated genes. Together, these data indicate that aberrant levels and activity of miR-9 may be one of the many factors that contribute to SZ risk, at least in a subset of patients. Topol et al. examine the role of decreased miR-9 levels in a subset of schizophrenia patient-derived neural progenitor cells from two independent cohorts. They observe a strong correlation between miR-9 expression and miR-9 regulatory activity. Manipulation of miR-9 impacts neural migration most likely through changes to many indirect miR-9 targets.
|Original language||English (US)|
|Number of pages||13|
|State||Published - May 3 2016|
- Human-induced pluripotent stem cell
- Neural progenitor cells
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)